Trial Profile
High- versus standard-dose atorvastatin in patients with newly diagnosed unstable angina and borderline vulnerable plaque lesions
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Unstable angina pectoris
- Focus Therapeutic Use
- 03 Sep 2013 New trial record